Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01992445 · ClinicalTrials.gov registry record
Suicidal Thought and Biological Markers
A clinical trial of Suicidal Intention, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- 375
- Enrollment target
- 3
- Study locations
NCT01992445: Completed study of Suicidal Intention, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT01992445 is a study of Suicidal Intention that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 375 participants, above the 79-participant average among 4 other Suicidal Intention trials with a reported enrollment target (375% higher). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01992445, a study of Suicidal Intention, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- 375 participants
- Enrollment target
- 3
- Study locations
Study Summary
Thought Markers (Tm) and Biomarkers(Bm) to accurately predict the likelihood of a repeated suicide attempt.
Primary Outcome
Questionnaire
Conditions Studied
Study Locations (3)
Ohio
- CCHMC - Cincinnati
- University of Cincinnati - Cincinnati
West Virginia
- Princeton Community Hospital - Princeton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 375 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-03 |
What the finished NCT01992445 record still lists
NCT01992445 is an observational study that tracks outcomes without assigning an intervention. The registered 375 participants enrollment target is mid-sized for trials with a published cap, above the 79-participant average among 4 other Suicidal Intention trials with a reported enrollment target (375% higher).
The record links to 1 condition, with Suicidal Intention appearing as the primary indexed condition, and to 0 interventions.
NCT01992445 reports a single indexed study location in Ohio, West Virginia.
Frequently Asked Questions
What is clinical trial NCT01992445 about?
NCT01992445 is a clinical study titled "Suicidal Thought and Biological Markers". Thought Markers (Tm) and Biomarkers(Bm) to accurately predict the likelihood of a repeated suicide attempt.
What is the current status of trial NCT01992445?
This trial is currently completed. The enrollment target is 375 participants. The study started on 2013-10. Estimated completion is 2015-03.
What conditions does trial NCT01992445 study?
This clinical trial studies the following conditions: Suicidal Intention.
Who is sponsoring clinical trial NCT01992445?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01992445 being conducted?
This trial has 3 study locations across Ohio, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicidal Intention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03686124 · 375 participants · Phase 1
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- NCT04059172 · 375 participants · Early Phase 1
Efficacy of Combined Ibuprofen and Acetaminophen Therapy Versus Ibuprofen Alone Versus Placebo Alone for Pain Management
- NCT04134923 · 375 participants
Imaging Biomarkers in Preclinical and Symptomatic AD
- NCT04569747 · 375 participants · Phase 2
A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia